Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $15.6M

Reported trades

Filed Stock Type Shares Price Value Since
Oct 2SEC PTGXProtagonist Therapeutics, Inc Sell Plan 12,595105,037 held (−11%) $141.77 $1.8M +1.4%
Oct 2SEC PTGXProtagonist Therapeutics, Inc Sell Plan 46,03459,003 held (−44%) $141.78 $6.5M +1.4%
Apr 21SEC PTGXProtagonist Therapeutics, Inc Sell 1,75059,003 held (−3%) $105.47 $185K +36.3%
Mar 27SEC PTGXProtagonist Therapeutics, Inc Sell 24,76560,753 held (−29%) $104.24 $2.6M +37.9%
Jan 27SEC PTGXProtagonist Therapeutics, Inc Sell 28,00078,523 held (−26%) $83.13 $2.3M +72.9%
Jan 27SEC PTGXProtagonist Therapeutics, Inc Sell 18,20360,320 held (−23%) $83.14 $1.5M +72.9%
Jan 21SEC PTGXProtagonist Therapeutics, Inc Sell 8,58878,077 held (−10%) $82.48 $708K +74.3%
  • Sell

    CFO Asif Ali sold $1.8M of PTGX at $141.77 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Asif Ali sold $6.5M of PTGX at $141.78 — cuts the stake by 44%; pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Asif Ali sold $2.6M of PTGX at $104.24 — cuts the stake by 29%.

  • Sell

    CFO Asif Ali sold $2.3M of PTGX at $83.13 — cuts the stake by 26%.